$ACUT
Accustem Sciences Inc.

2022 Q4 Form 10-Q Financial Statement

#000149315222030905 Filed on November 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3 2021 Q3
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $844.5K $840.0K
YoY Change
% of Gross Profit
Research & Development $133.1K $58.27K $14.13K
YoY Change 312.53%
% of Gross Profit
Depreciation & Amortization $910.00 $907.00 $0.00
YoY Change
% of Gross Profit
Operating Expenses $978.5K $899.1K $62.72K
YoY Change 1333.51%
Operating Profit -$899.1K -$62.72K
YoY Change 1333.51%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$978.5K -$899.1K -$62.72K
YoY Change 1333.51%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$978.5K -$899.1K -$62.72K
YoY Change 1333.51%
Net Earnings / Revenue
Basic Earnings Per Share -$0.08 -$0.01
Diluted Earnings Per Share -$0.09 -$0.08
COMMON SHARES
Basic Shares Outstanding 11.35M shares 11.34M shares 9.999M shares
Diluted Shares Outstanding 11.34M shares

Balance Sheet

Concept 2022 Q4 2022 Q3 2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $734.0K $1.332M
YoY Change
Cash & Equivalents $734.0K $1.332M
Short-Term Investments
Other Short-Term Assets $29.60K $282.1K
YoY Change
Inventory
Prepaid Expenses $168.4K $282.1K
Receivables
Other Receivables
Total Short-Term Assets $932.0K $1.614M
YoY Change -31.13%
LONG-TERM ASSETS
Property, Plant & Equipment $7.678K $8.585K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $7.678K $8.585K
YoY Change
TOTAL ASSETS
Total Short-Term Assets $932.0K $1.614M
Total Long-Term Assets $7.678K $8.585K
Total Assets $939.7K $1.623M
YoY Change -30.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $311.8K $154.9K
YoY Change -19.77%
Accrued Expenses $518.6K $349.2K
YoY Change 321.03%
Deferred Revenue
YoY Change
Short-Term Debt $106.6K $212.1K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.079M $824.9K
YoY Change 53.58%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $1.079M $824.9K
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $1.079M $824.9K
YoY Change 53.58%
SHAREHOLDERS EQUITY
Retained Earnings -$4.471M -$3.493M
YoY Change 516.85%
Common Stock $11.35K $11.35K
YoY Change 13.47%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$139.6K $797.7K $1.189M
YoY Change
Total Liabilities & Shareholders Equity $939.7K $1.623M
YoY Change -30.57%

Cashflow Statement

Concept 2022 Q4 2022 Q3 2021 Q3
OPERATING ACTIVITIES
Net Income -$978.5K -$899.1K -$62.72K
YoY Change 1333.51%
Depreciation, Depletion And Amortization $910.00 $907.00 $0.00
YoY Change
Cash From Operating Activities -$490.7K -$1.315M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $0.00 $11.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities $0.00 -$11.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -107.3K 2.658M
YoY Change
NET CHANGE
Cash From Operating Activities -490.7K -1.315M
Cash From Investing Activities 0.000 -11.00K
Cash From Financing Activities -107.3K 2.658M
Net Change In Cash -598.0K 1.332M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$490.7K -$1.315M
Capital Expenditures $0.00 $11.00K
Free Cash Flow -$490.7K -$1.326M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q3 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
CY2021Q4 us-gaap Notes Payable Current
NotesPayableCurrent
usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
ACUT
dei Entity Central Index Key
EntityCentralIndexKey
0001850767
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2021Q4 us-gaap Cash
Cash
usd
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2022Q3 ACUT Subscription Receivable Related Party
SubscriptionReceivableRelatedParty
usd
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2021Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
usd
us-gaap Depreciation
Depreciation
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
ACUT Proceeds From Receipt Of Subscription Receivable
ProceedsFromReceiptOfSubscriptionReceivable
usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
us-gaap Notes Issued1
NotesIssued1
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
usd
us-gaap Depreciation
Depreciation
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56257
dei Entity Registrant Name
EntityRegistrantName
ACCUSTEM SCIENCES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-3774438
dei Entity Address Address Line1
EntityAddressAddressLine1
5 Penn Plaza
dei Entity Address Address Line2
EntityAddressAddressLine2
19th Floor
dei Entity Address City Or Town
EntityAddressCityOrTown
#1954 New York
dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10001
dei City Area Code
CityAreaCode
00 44
dei Local Phone Number
LocalPhoneNumber
2074952379
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
11346535 shares
CY2022Q3 us-gaap Cash
Cash
1331960 usd
CY2021Q4 us-gaap Due From Related Parties Current
DueFromRelatedPartiesCurrent
1353373 usd
CY2022Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
282113 usd
CY2022Q3 us-gaap Assets Current
AssetsCurrent
1614073 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1353373 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8585 usd
CY2022Q3 us-gaap Assets
Assets
1622658 usd
CY2021Q4 us-gaap Assets
Assets
1353373 usd
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
154889 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
388681 usd
CY2022Q3 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
108806 usd
CY2021Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
190838 usd
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
349183 usd
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
123181 usd
CY2022Q3 us-gaap Notes Payable Current
NotesPayableCurrent
212056 usd
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
824934 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
702700 usd
CY2022Q3 us-gaap Liabilities
Liabilities
824934 usd
CY2021Q4 us-gaap Liabilities
Liabilities
702700 usd
CY2022Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2022Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
150000000 shares
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
11346535 shares
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
11346535 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
9999132 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
9999132 shares
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
11346 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
9999 usd
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
4279125 usd
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1503434 usd
CY2021Q4 ACUT Subscription Receivable Related Party
SubscriptionReceivableRelatedParty
-204879 usd
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
66981 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3492747 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-724862 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
797724 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
650673 usd
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1622658 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1353373 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
58270 usd
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14125 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
133809 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
46869 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
840855 usd
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48597 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2634076 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
80263 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
899125 usd
CY2021Q3 us-gaap Operating Expenses
OperatingExpenses
62722 usd
us-gaap Operating Expenses
OperatingExpenses
2767885 usd
us-gaap Operating Expenses
OperatingExpenses
127132 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-899125 usd
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-62722 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-2767885 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-127132 usd
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-899125 usd
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-62722 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-2767885 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-127132 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-899125 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-62722 usd
us-gaap Net Income Loss
NetIncomeLoss
-2767885 usd
us-gaap Net Income Loss
NetIncomeLoss
-127132 usd
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11337668 shares
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9999132 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10904423 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9999132 shares
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-899125 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-62722 usd
us-gaap Net Income Loss
NetIncomeLoss
-2767885 usd
us-gaap Net Income Loss
NetIncomeLoss
-127132 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
33433 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Translation Adjustment Tax
OtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentTax
16347 usd
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-899125 usd
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-96155 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2767885 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-143479 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
1650566 usd
CY2022Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
38001 usd
CY2022Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8282 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-899125 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
797724 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
1260207 usd
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21260 usd
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-29359 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-62722 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1189386 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
650673 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
92629 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2675940 usd
us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
204879 usd
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8469 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-66981 usd
us-gaap Net Income Loss
NetIncomeLoss
-2767885 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
797724 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
1309796 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
21260 usd
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-14538 usd
us-gaap Net Income Loss
NetIncomeLoss
-127132 usd
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
1189386 usd
us-gaap Net Income Loss
NetIncomeLoss
-2767885 usd
us-gaap Net Income Loss
NetIncomeLoss
-127132 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
66981 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
14538 usd
us-gaap Depreciation
Depreciation
2414 usd
us-gaap Share Based Compensation
ShareBasedCompensation
92629 usd
us-gaap Share Based Compensation
ShareBasedCompensation
21260 usd
ACUT Increase Decrease In Related Party Receivable
IncreaseDecreaseInRelatedPartyReceivable
1353373 usd
ACUT Increase Decrease In Related Party Receivable
IncreaseDecreaseInRelatedPartyReceivable
18586 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-157009 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-233791 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
41414 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
82033 usd
us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-60983 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
229940 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-573 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1315325 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
10999 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-10999 usd
ACUT Proceeds From Receipt Of Subscription Receivable
ProceedsFromReceiptOfSubscriptionReceivable
204879 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2675940 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8469 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
231004 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
2658284 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1331960 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1331960 usd
us-gaap Notes Issued1
NotesIssued1
439122 usd
us-gaap Interest Paid Net
InterestPaidNet
5726 usd
us-gaap Net Income Loss
NetIncomeLoss
-2767885 usd
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-3492747 usd
CY2022Q3 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_z1GSsh6Px9Mi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Use of Estimates </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management of the Company to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income and expenses during the reporting period. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0 usd
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9999132 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
10904423 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9999132 shares
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022Q1 us-gaap Investments
Investments
2765940 usd
CY2022Q1 us-gaap Investments
Investments
2000000 gbp
CY2022Q1 us-gaap Conversion Of Stock Shares Issued1
ConversionOfStockSharesIssued1
1337970 shares
CY2022Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-899125 usd
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-62722 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2767885 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-127132 usd
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
11337668 shares
CY2022Q3 us-gaap Notes Payable
NotesPayable
212056 usd
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
10999 usd
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2414 usd
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8585 usd
CY2022Q3 us-gaap Depreciation
Depreciation
907 usd
CY2021Q3 us-gaap Depreciation
Depreciation
0 usd
us-gaap Depreciation
Depreciation
2414 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-899125 usd
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-62722 usd
us-gaap Net Income Loss
NetIncomeLoss
-2767885 usd
us-gaap Net Income Loss
NetIncomeLoss
-127132 usd
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.25
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2022Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
207825 shares
CY2021Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100005 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
207825 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
100005 shares
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100005 shares
CY2021 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.42
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2021Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
100005 shares
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0154 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0234 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.572 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.657 pure
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
904780 usd
CY2022Q3 us-gaap Related Party Costs
RelatedPartyCosts
4708 usd
CY2021Q3 us-gaap Related Party Costs
RelatedPartyCosts
2986 usd
us-gaap Related Party Costs
RelatedPartyCosts
31154 usd
us-gaap Related Party Costs
RelatedPartyCosts
9166 usd

Files In Submission

Name View Source Status
0001493152-22-030905-index-headers.html Edgar Link pending
0001493152-22-030905-index.html Edgar Link pending
0001493152-22-030905.txt Edgar Link pending
0001493152-22-030905-xbrl.zip Edgar Link pending
acut-20220930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
form10-q_001.jpg Edgar Link pending
form10-q_002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
acut-20220930_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
acut-20220930_def.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
acut-20220930_pre.xml Edgar Link unprocessable
acut-20220930_lab.xml Edgar Link unprocessable
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending